Fetal Monitors in North Carolina

Laboratory Corporation of America Holdings (Labcorp) is a global leader in laboratory services headquartered in Burlington, North Carolina. Operating in approximately 100 countries with over 70,000 employees, Labcorp performs more than 700 million tests annually and generates $13.01 billion in revenue. The company provides comprehensive clinical diagnostics, drug development support, and specialized testing including oncology, rare diseases, and genomic sequencing. Labcorp's integrated platform connects diagnostics to biopharma development, supporting healthcare providers, researchers, and investigators. Key offerings include AI-powered diagnostic assistance tools, real-world data platforms for drug development, genetic testing services (including Invitae), nonclinical research, central laboratory services, and clinical trial support. The company serves patients, healthcare providers, health systems, managed care organizations, and biopharmaceutical companies. Over 75% of new drugs approved by the FDA have been supported by Labcorp's services.

PeriGen is a perinatal healthcare software company with over 27 years of experience developing solutions for labor and delivery management. The company specializes in maternal-fetal surveillance and early warning systems designed to prevent complications during childbirth. PeriGen's flagship platform, PeriWatch, includes advanced fetal heart rate pattern analysis, automated risk detection, and clinical decision support tools. The company's solutions integrate with electronic fetal monitoring systems and electronic medical records to provide real-time data analysis and clinician alerts. PeriWatch Vigilance uses FDA-cleared machine learning algorithms to continuously interpret fetal heart rate patterns and detect labor progress anomalies. Additional offerings include centralized monitoring command centers, mobile applications for clinician access, quality reporting dashboards, and automated safety threshold notifications. PeriGen serves over 500 hospitals across the United States and Canada, supporting approximately 750,000 births annually. The company emphasizes responsible AI implementation that complements rather than replaces clinical expertise, with published outcomes data demonstrating impact on maternal and fetal safety.